Meet Dr. David Scott Miller
Gynecologic Oncology Specialist

 
Holder of the:
Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
Dallas Foundation Chair in Gynecologic Oncology

Early in his career, David Scott Miller, M.D., decided that his mission was helping women with their journey through cancer. He believes that no matter what the cancer diagnosis is, it brings a sense of urgency and clarity to a person’s life. This is part of the driving force behind his nationally and internationally recognized work to improve the evaluation and treatment of gynecologic cancers.

When and where the cancer is diagnosed will have an impact on a woman’s chances of surviving the disease. It is extremely important to have one doctor trained in all aspects of evaluating and treating gynecologic cancer committed to the patient.”

Cancers affecting a woman’s reproductive system (including the ovaries, uterus, cervix, vagina, vulva, and placenta) can be complex. Dr. Miller and his team bring a comprehensive approach to care that offers patients unique access to the newest findings and technology to evaluate disease, innovative therapies and surgical care, exceptional support services, and groundbreaking research and clinical trials.

Since joining UT Southwestern in 1991, Dr. Miller has assembled a team focused completely on gynecologic cancers. This team includes faculty physicians – trained and board certified in obstetrics and gynecology – who have gone on to complete fellowship training in gynecologic oncology. They are experts in gynecology and the cancers that affect the female reproductive tract, and passionate about caring for women with gynecologic cancer.

An advocate of providing the newest options available to patients, Dr. Miller says UT Southwestern is on the cutting edge of surgical and medical innovations to eliminate gynecologic cancer. This includes state-of-the-art minimally invasive and robotic procedures to remove tumors, fertility-sparing procedures, and targeted therapies to attack cancer cells without damaging noncancerous tissue.

Dr. Miller serves as a principal investigator for the National Cancer Institute’s Gynecologic Oncology Group and participates in the evaluation and cancer treatment protocols developed by that organization. UT Southwestern is the only institution in north Texas that is a member of the National Institutes of Health’s (NIH) Gynecologic Oncology Group. This Group is the hub of major research and innovations for gynecologic cancers.

Board certified both in obstetrics and gynecology and in gynecologic oncology, Dr. Miller is consistently included in the D Magazine list of Best Doctors in Dallas and as a Texas Monthly Super Doctor. He is a member of the Society of Gynecologic Oncology, the American Society of Clinical Oncology, the American Congress of Obstetricians and Gynecologists, and the American College of Surgeons.

Clinical Interests

Gynecologic Oncology

  • Cervical cancer
  • Uterine cancer
  • Endometrial cancer
  • Ovarian cancer
  • Placental cancer
  • Vaginal cancer
  • Vulvar cancer

Fertility-Sparing Surgery

Minimally Invasive Surgery